Clinical outcome in prostate cancer treated with magnetic resonance imaging-guided high-dose-rate brachytherapy combined with external beam radiotherapy

References

• Moon DH, Efstathiou JA, Chen RC. What is the best way to radiate the prostate in 2016? Urol Oncol Semin Orig Investig. 2016;35:1–10.
   Web of Science ®Google Scholar
• Ágoston P, Major T, Fröhlich G, et al. Moderate dose escalation with single-fraction high-dose-rate brachytherapy boost for clinically localized intermediate- and high-risk prostate cancer: 5-year outcome of the first 100 consecutively treated patients. Brachytherapy. 2011;10:376–384.
   PubMed Web of Science ®Google Scholar
• Hoskin PJ, Rojas AM, Bownes PJ, et al. Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer. Radiother Oncol. 2012;103:217–222.
   PubMed Web of Science ®Google Scholar
• Martínez-Monge R, Moreno M, Ciérvide R, et al. External-beam radiation therapy and high-dose rate brachytherapy combined with long-term androgen deprivation therapy in high and very high prostate cancer: preliminary data on clinical outcome. Int J Radiat Oncol Biol Phys. 2012;82:469–476.
   PubMed Web of Science ®Google Scholar
• Sathya JR, Davis IR, Julian JA, et al. Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate. JCO. 2005;23:1192–1199.
   PubMed Web of Science ®Google Scholar
• Pistis F, Guedea F, Pera J, et al. External beam radiotherapy plus high-dose-rate brachytherapy for treatment of locally advanced prostate cancer: the initial experience of the Catalan Institute of Oncology. Brachytherapy. 2010;9:15–22.
   PubMed Web of Science ®Google Scholar
• Ahmed HU, El-Shater Bosaily A, Brown LC, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389:815–822.
   PubMed Web of Science ®Google Scholar
• Simmons LAM, Kanthabalan A, Arya M, et al. The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy. Br J Cancer. 2017;116:1159–1165.
   PubMed Web of Science ®Google Scholar
• Damkjær S, Thomsen JB, Petersen SI, et al. A modeling study of functional magnetic resonance imaging to individualize target definition of seminal vesicles for external beam radiotherapy. Acta Oncol. 2017;56:799–805.
   PubMed Web of Science ®Google Scholar
• Feng Y, Welsh D, McDonald K, et al. Identifying the dominant prostate cancer focal lesion using image analysis and planning of a simultaneous integrated stereotactic boost. Acta Oncol. 2015;54:1543–1550.
   PubMed Web of Science ®Google Scholar
• Vigneault E, Mbodji K, Racine LG, et al. Image-guided high-dose-rate brachytherapy boost to the dominant intraprostatic lesion using multiparametric magnetic resonance imaging including spectroscopy: results of a prospective study. Brachytherapy. 2016;15:746–751.
   PubMed Web of Science ®Google Scholar
• Gomez-Iturriaga A, Casquero F, Urresola A, et al. Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion high-dose-rate prostate brachytherapy. Prospective phase II trial. Radiother Oncol. 2016;119:91–96.
   PubMed Web of Science ®Google Scholar
• Lakosi F, de Cuypere M, Viet Nguyen P, et al. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: a mono-institutional experience. Acta Oncol. 2015;54:1558–1566.
   PubMed Web of Science ®Google Scholar
• Lindegaard JC, Fokdal LU, Nielsen SK, et al. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Acta Oncol. 2013;52:1510–1519.
   PubMed Web of Science ®Google Scholar
• Ares C, Popowski Y, Pampallona S, et al. Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot study. Int J Radiat Oncol Biol Phys. 2009;75:656–663.
   PubMed Web of Science ®Google Scholar
• Blanchard P, Ménard C, Frank SJ. Clinical use of magnetic resonance imaging across the prostate brachytherapy workflow. Brachytherapy. 2017. DOI:10.1016/j.brachy.2016.11.012
   Web of Science ®Google Scholar
• Buus S, Rylander S, Hokland S, et al. Learning curve of MRI-based planning for high-dose-rate brachytherapy for prostate cancer. Brachytherapy. 2016;15:426–434.
   PubMed Web of Science ®Google Scholar
• Lakosi F, Antal G, Vandulek C, et al. Technical feasibility of transperineal MR-guided prostate interventions in a low-field open MRI unit: Canine study. Pathol Oncol Res. 2009;15:315–322.
   PubMed Web of Science ®Google Scholar
• Lakosi F, Antal G, Vandulek C, et al. Open MR-guided high-dose-rate (HDR) prostate brachytherapy: feasibility and initial experiences open MR-guided high-dose-rate (HDR) prostate brachytherapy. Pathol Oncol Res. 2011;17:315–324.
   PubMed Web of Science ®Google Scholar
• Ménard C, Susil RC, Choyke P, et al. MRI-guided HDR prostate brachytherapy in standard 1.5 T scanner. Int J Radiat Oncol Biol Phys. 2004;59:1414–1423.
   PubMed Web of Science ®Google Scholar
• Murgic J, Chung P, Berlin A, et al. Lessons learned using an MRI-only workflow during high-dose-rate brachytherapy for prostate cancer. Brachytherapy. 2016;15:147–155.
   PubMed Web of Science ®Google Scholar
• Choudhury A, Arthur C, Malik J, et al. Patient-reported outcomes and health-related quality of life in prostate cancer treated with a single fraction of high dose rate brachytherapy combined with hypofractionated external beam radiotherapy. Clin Oncol. 2014;26:661–667.
   Web of Science ®Google Scholar
• Díez P, Mullassery V, Dankulchai P, et al. Dosimetric analysis of urethral strictures following HDR 192Ir brachytherapy as monotherapy for intermediate- and high-risk prostate cancer. Radiother Oncol. 2014;113:410–413.
   PubMed Web of Science ®Google Scholar
• Hindson BR, Millar JL, Matheson B. Urethral strictures following high-dose-rate brachytherapy for prostate cancer: analysis of risk factors. Brachytherapy. 2013;12:50–55.
   PubMed Web of Science ®Google Scholar
• Hoskin PJ, Rojas AM, Ostler PJ, et al. Quality of life after radical radiotherapy for prostate cancer: longitudinal study from a randomised trial of external beam radiotherapy alone or in combination with high dose rate brachytherapy. Clin Oncol (R Coll Radiol). 2013;25:321–327.
   PubMed Web of Science ®Google Scholar
• Hjälm-Eriksson M, Ullén A, Johansson H, et al. Comorbidity as a predictor of overall survival in prostate cancer patients treated with external beam radiotherapy combined with HDR brachytherapy boosts. Acta Oncol. 2017;56:21–26.
   PubMed Web of Science ®Google Scholar